Abstract 16429: Neuro-endocrino-immunological PBMC Signatures Early After Mechanical Support Device Implantation

Abstract

Background: The neuro-endocrino-immunological (NEI) pathophysiology associated with advanced heart failure (AdHF) progression and arrythmogenesis is not well understood. While it has been shown that mechanical circulatory support device (MCSD) implantation rapidly restores normal hemodynamics, it is unknown as to whether NEI mechanisms also normalize rapidly. We hypothesized that transcriptional activity in PBMC reflecting NEI normalizes shortly after MCSD implantation. Methods: We collected PBMC samples from 25 MCSD patients and 4 healthy controls (CTRL). Samples were obtained at 1 day before, and 1, 3, 5 and 8 days after MCSD. Purified mRNA was subjected to whole-genome NGS analysis. Statistically significant genes, dysregulated between AdHF patients and CTRLs, were subjected to time dependent bioinformatics analysis. Results: We identified 1226 dysregulated gene-transcripts between AdHF patients and CRTLs at baseline. Time dependent analysis provided 344 dysregulated transcripts in AdHF patients across all time-points. An analysis of enriched molecular pathways by dysregulated genes showed 52 pathways with NEI annotations at baseline. The Endothelin pathway, one of the most significant of the 52 pathways, had 17/60 dysregulated transcripts in AdHF patients at baseline and through day 8 after implantation (Fig.1A). Within the Endothelin pathway we found that expression of EDNRB, a gene central to ET1 clearance and ECE-inhibition, is persistently elevated through day 8 after MCSD (Fig.1B). Conclusion: Transcriptional NEI dysregulation is persistent in PBMC 8 days after MCSD implantation. Neuromodulatory strategies targeted at NEI dysregulation and implemented after MCSD implantation may be a mechanism to improve perioperative outcomes. Further studies including validation methods to objectively assess NEI activity are warranted.